Innovating Works

EXEVIR BIO

Desconocido
XVR011 Phase 2: ExeVir's XVR011, a best in class nanobody-based biology that broadly neutralizes SARS-COV-1 and SARS... EXEVIR BIO tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-CORONA-01 XVR011, ExeVir's clinical lead candidate has emerged from scientific research from labs of highly regarded virologist Xavier Saelens and bio...
2021-11-15 - 2022-11-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.